These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4127854)

  • 41. Activation of peripheral lymphocytes in the course of experimental allergic encephalomyelitis in the guinea-pig.
    Pekárek J; Vepreková A; Doutlík S
    Z Immunitatsforsch Exp Klin Immunol; 1972 Mar; 143(2):139-46. PubMed ID: 4143076
    [No Abstract]   [Full Text] [Related]  

  • 42. Susceptibility and resistance to experimental autoimmune encephalomyelitis and neuritis in the guinea pig correlate with the induction of procoagulant and anticoagulant activities.
    Geczy CL; Roberts IM; Meyer P; Bernard CC
    J Immunol; 1984 Dec; 133(6):3026-36. PubMed ID: 6208270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
    Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
    Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antibody reaction to basic myelin proteins after intracisternal administration into animals].
    Mendzheritskiĭ AM
    Vopr Med Khim; 1984; 30(5):106-10. PubMed ID: 6084891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro effects of phytohemagglutinin and brain antigen on cell transfer of experimental autoimmune encephalomyelitis in Lewis rats.
    Flad HD; Paterson PY; Mischer PA
    J Immunol; 1968 Mar; 100(3):647-53. PubMed ID: 5643078
    [No Abstract]   [Full Text] [Related]  

  • 46. Studies of cyclophosphamide suppression of experimental allergic encephalomyelitis in Wistar rats.
    Paterson PY; Hanson MA
    J Immunol; 1969 Oct; 103(4):795-803. PubMed ID: 5349735
    [No Abstract]   [Full Text] [Related]  

  • 47. Transformation of lymphocytes from monkeys with experimental allergic encephalomyelitis.
    Chaparas SD; Clark RG; Kies MW; Hedrick SR
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):637-52. PubMed ID: 5002788
    [No Abstract]   [Full Text] [Related]  

  • 48. Relationships between antibodies and experimental allergic encephalomyelitis. 3. Coprecipitation and radioautography of 125I-labeled antigen-antibody complexes for detection of antibodies to myelin basic protein.
    Lisak RP; Heinze RG; Kies MW
    Int Arch Allergy Appl Immunol; 1970; 37(6):621-9. PubMed ID: 4983347
    [No Abstract]   [Full Text] [Related]  

  • 49. Suppression of experimental allergic encephalomyelitis in guinea/pigs by liposome-associated human myelin basic protein.
    Strejan GH; Percy DH; St Louis J; Surlan D; Paty DW
    J Immunol; 1981 Nov; 127(5):2064-9. PubMed ID: 6170686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Basic protein from central nervous system myelin.
    Hashim GA
    Prog Clin Biol Res; 1980; 49():79-122. PubMed ID: 6163164
    [No Abstract]   [Full Text] [Related]  

  • 51. [Correlation between brain lesion lateralization and immunologic indices in a model of experimental allergic encephalomyelitis].
    Abramchik GV; Ermakova SS; Tanina RM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(2):153-9. PubMed ID: 425758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of experimental allergic encephalomyelitis with encephalitogenic basic proteins.
    Levine S; Sowinski R; Kies MW
    Proc Soc Exp Biol Med; 1972 Feb; 139(2):506-10. PubMed ID: 4621748
    [No Abstract]   [Full Text] [Related]  

  • 53. [Suppressant effect of unrelated antigens on the development of allergic encephalomyelitis].
    Zhitnukhin IuL; Karasik OA; Sofronov BN
    Patol Fiziol Eksp Ter; 1978; (4):58-61. PubMed ID: 704163
    [No Abstract]   [Full Text] [Related]  

  • 54. [Study of the mechanism of action of tegretol in experimental allergic encephalomyelitis].
    Danusevich IK; Korin MM; Nedz'ved' GK; Shal'kevich VB; Alpatova AI
    Farmakol Toksikol; 1975; 38(2):210-4. PubMed ID: 1227893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glucocorticoids and experimental allergic encephalomyelitis--nonspecific versus specific immunomodulation of autoimmunity.
    Teitelbaum D
    Isr J Med Sci; 1991 Jul; 27(7):400-2. PubMed ID: 2071379
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of live attenuated vaccines on the course of experimental allergic encephalomyelitis. A pilot study.
    Caspary EA
    Eur Neurol; 1977; 16(1-6):176-80. PubMed ID: 567120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental allergic encephalomyelitis: dissociation of neurological symptoms from lipid alterations in brain.
    Maggio B; Cumar FA
    Nature; 1975 Jan; 253(5490):364-5. PubMed ID: 46110
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of imuran (azathioprine) on susceptibility of guinea pigs to allergic encephalomyelitis.
    Field EJ
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):138-41. PubMed ID: 6030233
    [No Abstract]   [Full Text] [Related]  

  • 59. [D. Effect of high molecular levan on experimental allergic encephalitis].
    Berman Z; Techetchik ; Stern N
    Harefuah; 1977 Dec; 93(11):340-3. PubMed ID: 608644
    [No Abstract]   [Full Text] [Related]  

  • 60. Partial suppression of experimental allergic encephalomyelitis with heparin.
    Chelmicka-Szorc E; Arnason BG
    Arch Neurol; 1972 Aug; 27(2):153-8. PubMed ID: 5040633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.